In one paragraphArticle in Science advances, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
2 · The registryThe trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
3 · Its place in the literatureWho cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
4 · The recordCorrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
5 · Who and what moneyAuthors and funding
12 authors.
Jiwon KimDepartment of Biomedical Sciences, Seoul National University College of Medicine, Seoul 03080, Republic of Korea.ORCID 0000-0001-7247-3868 Jaeik OhDepartment of Translational Medicine, Seoul National University College of Medicine, Seoul 03080, Republic of Korea.ORCID 0000-0002-6863-4590 Dongjun JangDepartment of Biomedical Sciences, Seoul National University College of Medicine, Seoul 03080, Republic of Korea.
Seungjae ShinDepartment of Biomedical Sciences, Seoul National University College of Medicine, Seoul 03080, Republic of Korea.ORCID 0009-0007-6599-8325 Soo-Jin LeeDepartment of Biomedical Sciences, Seoul National University College of Medicine, Seoul 03080, Republic of Korea.ORCID 0000-0001-5520-6522 Sang Eun LeeDepartment of Biomedical Sciences, Seoul National University College of Medicine, Seoul 03080, Republic of Korea.
Yoojin YangDepartment of Biomedical Sciences, Seoul National University College of Medicine, Seoul 03080, Republic of Korea.ORCID 0009-0003-0045-8484 Dohee KimDepartment of Biomedical Sciences, Seoul National University College of Medicine, Seoul 03080, Republic of Korea.
Ae Jin ChoiMedical Research Center, Genomic Medicine Institute, Seoul National University College of Medicine, Seoul 03080, Republic of Korea.
Hae Rim JungMedical Research Center, Genomic Medicine Institute, Seoul National University College of Medicine, Seoul 03080, Republic of Korea.ORCID 0009-0002-8307-2474 Yumi OhMedical Research Center, Genomic Medicine Institute, Seoul National University College of Medicine, Seoul 03080, Republic of Korea.
Sung-Yup ChoDepartment of Biomedical Sciences, Seoul National University College of Medicine, Seoul 03080, Republic of Korea.ORCID 0000-0002-2720-6952 Funding
No grant is acknowledged in the PubMed record.
6 · The paper itselfAbstract
PubMed holds no abstract for this paper.
Indexed as
DNA-Binding ProteinsDNA DamageNeoplasmsTranscription FactorsAnimalsCell Line, TumorCheckpoint Kinase 1Checkpoint Kinase 2Cyclin-Dependent Kinase Inhibitor p21Enzyme InhibitorsFemaleHumansMiceMolecular Targeted TherapyMutationNuclear ProteinsARID1A protein, humanCheckpoint Kinase 1Checkpoint Kinase 2Cyclin-Dependent Kinase Inhibitor p21DNA-Binding ProteinsEnzyme InhibitorsNuclear ProteinsTranscription FactorsWerner Syndrome HelicaseWRN protein, human
Identifiers
PMID42247504
PMCPMC13240190
What OpenQuestion holds
Textmetadata
LicenceCC BY-NC
Read underepoch 390